Skip to content

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-206.2%-61.0pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-168.6%-52.7pp
Immunome logo
ImmunomeIMNM
-5,947.9%-12,002pp
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-2,776.6%-820pp
Nuvation Bio logo
Nuvation BioNUVB
-105%-52.0pp

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Calculated from IDEAYA Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: IDEAYA Biosciences, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s operating margin?
IDEAYA Biosciences, Inc. (IDYA) reported operating margin of -4,671.1% in Q4 2024.
How has IDEAYA Biosciences, Inc.'s operating margin changed year-over-year?
IDEAYA Biosciences, Inc.'s operating margin decreased by 712.5% year-over-year, from -574.9% to -4,671.1%.
What is the long-term trend for IDEAYA Biosciences, Inc.'s operating margin?
Over 3 years (2021 to 2024), IDEAYA Biosciences, Inc.'s operating margin has grown at a 196.1% compound annual growth rate (CAGR), from -179.9% to -4,671.1%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.